doxazosin and dutasteride

doxazosin has been researched along with dutasteride in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's7 (58.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brown, GA; Sussman, DO1
Barnett, G; Brown, CT; Ellis, BW; Emberton, M; Ryan, M; Watson, V1
O'Leary, MP1
Gratzke, C; Reich, O; Schlenker, B; Seitz, M; Stief, CG; Weidlich, P1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA1
Kuo, HC; Liao, CH; Lin, VC; Wang, CC1
Kuo, HC; Liao, CH; Lin, VC1
Zisman, A1
Carini, M; Corona, G; Ficarra, V; Gacci, M; Maggi, M; Novara, G; Sebastianelli, A; Serni, S; Shariat, SF; Zattoni, F1
Arenas-Duque, A; Garcia-Perdomo, HA; Guevara-Cuellar, CA; Parody-Rúa, E1

Reviews

4 review(s) available for doxazosin and dutasteride

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Treatment and pharmacologic management of BPH in the context of common comorbidities.
    The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome

2006
[Benign prostatic hyperplasia: medical therapy].
    MMW Fortschritte der Medizin, 2007, Aug-16, Volume: 149, Issue:33-34

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenergic alpha-Antagonists; Algorithms; Azasteroids; Disease Progression; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Muscarinic Antagonists; Phosphodiesterase Inhibitors; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome

2007
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
    The journal of sexual medicine, 2014, Volume: 11, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Ejaculation; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urological Agents

2014

Trials

1 trial(s) available for doxazosin and dutasteride

ArticleYear
Progression of lower urinary tract symptoms after discontinuation of 1 medication from 2-year combined alpha-blocker and 5-alpha-reductase inhibitor therapy for benign prostatic hyperplasia in men--a randomized multicenter study.
    Urology, 2014, Volume: 83, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Disease Progression; Doxazosin; Drug Therapy, Combination; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Prostatic Hyperplasia; Time Factors

2014

Other Studies

7 other study(ies) available for doxazosin and dutasteride

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
A current review of medical therapy for benign prostatic hyperplasia.
    The Journal of the American Osteopathic Association, 2004, Volume: 104, Issue:2 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Algorithms; Azasteroids; Cholestenone 5 alpha-Reductase; Doxazosin; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Urination Disorders

2004
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.
    The Journal of urology, 2004, Volume: 172, Issue:6 Pt 1

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Azasteroids; Doxazosin; Dutasteride; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders

2004
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    The Journal of urology, 2010, Volume: 183, Issue:5

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin

2010
5α-Reductase inhibitor is less effective in men with small prostate volume and low serum prostatic specific antigen level.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Biopsy; Chi-Square Distribution; Disease Progression; Doxazosin; Drug Therapy, Combination; Dutasteride; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Quality of Life; Taiwan; Treatment Outcome

2015
Editorial comment.
    Urology, 2014, Volume: 83, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia

2014
Cost-Effectiveness of Combination Therapy Versus Monotherapy in Benign Prostatic Hyperplasia: A Colombian Experience.
    Value in health regional issues, 2018, Volume: 17

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Adult; Colombia; Cost-Benefit Analysis; Doxazosin; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia

2018